Follow The Filings

IPX IperionX

IperionX earnings company data as of 10:00 AM ET 10/10

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q2 29 Sep EPS -0.55 — —
Rev — — —

Insider trades

Open-market buys and sales by IPX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IPX insider trades
  • $7.8M bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Anastasios Arima CEO
    Buy
    $497K 138,720 shares at $3.58 +1.1% to stake
    Traded Jul 10 Filed Jul 13
  2. Todd Hannigan Chair
    Buy
    $1.9M 525,000 shares at $3.58 +2% to stake
    Traded Jul 10–13 Filed Jul 13
  3. Anastasios Arima CEO
    Buy
    $494K 110,000 shares at $4.49 +0.9% to stake
    Traded Apr 28 Filed Apr 30
  4. Todd Hannigan Chair
    Buy
    $2.1M 480,000 shares at $4.33 +1.9% to stake
    Traded Apr 28–29 Filed Apr 29
  5. Anastasios Arima CEO
    Buy
    $1.8M 479,800 shares at $3.74
    Traded Mar 27 Filed Mar 30
  6. Todd Hannigan Director
    Buy
    $721K 225,225 shares at $3.20 +0.9% to stake
    Traded Mar 27 Filed Mar 30
  7. Toby Edgcumbe Symonds President
    Buy
    $263K 11,000 shares at $23.87 New stake
    Traded Mar 27 Filed Mar 30
  8. R Tony Tripeny Director
    Buy
    $99K 4,187 shares at $23.76 New stake
    Traded Mar 27 Filed Mar 30

Also filed in the last 12 months, not counted as buying or selling: 1 stock grant and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
6-K
20-F
6-K
6-K
6-K
6-K
6-K
424B5
6-K
424B5
6-K
6-K
6-K
6-K/A
6-K
6-K
6-K
6-K
6-K
6-K
6-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.